StockData
Alamar Biosciences, Inc. logo

Alamar Biosciences, Inc. (ALMR) company profile

ALMRNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 4, 2026
$30.64+0.09 (+0.29%)

Close on Nov 17, 2026Market cap $2.13BP/E –Yield –

About Alamar Biosciences

Laboratory Analytical Instruments, SIC 3826

Alamar Biosciences, Inc. is listed on Nasdaq under the ticker ALMR, in the SEC industry Laboratory Analytical Instruments. It is incorporated in Delaware and its fiscal year ends on December 31. Reported financials on StockData start in fiscal 2025.

Company profile

Company

Legal name
Alamar Biosciences, Inc.
Headquarters
Fremont, CA
Address
47071 Bayside Parkway 94538
Phone
(510) 626-9888
Industry
Laboratory Analytical Instruments
Incorporated in
Delaware
Fiscal year ends
December 31

Stock & identifiers

Ticker
ALMR
Exchange
Nasdaq
IPO date
Apr 17, 2026
Shares outstanding
69M, Jul 31, 2026
Filer category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SEC CIK
2104204
CUSIP
010911105
ISIN
US0109111056
FIGI
BBG012FD22W7
Share class FIGI
BBG012FD22X6
EIN
36-4899036

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Yuling LuoChief Executive Officer, Director5,888,675
Shiping ChenChief Operating Officer, Director1,445,770
John L. BrottemGeneral Counsel29,000
Timothy Ogden WhitePresident491,803
Justin J. McAnearChief Financial Officer37,220
Robert P. RagusaDirector5,686
Rebecca ChambersDirector–
Frank WitneyDirector–
Ian W. RatcliffeDirector–

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
Apr 17, 2026
Offer price
$17.00
Securities offered
11,250,000
Gross proceeds
$191.25M
Exchange
Nasdaq
First trading day
Apr 17, 2026
First-day close
$22.00+29.4%
Lock-up ends (est.)
Oct 14, 2026

“The initial public offering price is $17.00 per share.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Corporate history

Events identified from SEC filings

See a number that looks wrong?